Sourav Ghosh
Research Subjects
Sourav Ghosh has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Aditya Anand
Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India
2 shared publications Govindarajan Padmanaban
Department of Biochemistry, Indian Institute of Science, Bangalore, Karnataka, India
2 shared publicationsManjunatha Chandana
Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, Odisha, India
2 shared publications- Rahul Das
Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, India
2 shared publications - Viswanathan Arun Nagaraj
Infectious Disease Biology, Institute of Life Sciences, Bhubaneswar, Odisha, India
2 shared publications - Ajit Kumar Singh
The Hormel Institute, University of Minnesota, Austin, MN 55912, USA
1 shared publication
Latest Publications
- Open Access
- 4 March 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108379
Structure-function studies of a nucleoplasmin isoform from Plasmodium falciparum
- 4 March 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108379
Open AccessStructure-function studies of a nucleoplasmin isoform from Plasmodium falciparum
- Open Access
- 27 September 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (11) , 107829
Plasmodium berghei HMGB1 controls the host immune responses and splenic clearance by regulating the expression of pir genes
- 27 September 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (11) , 107829
Open AccessPlasmodium berghei HMGB1 controls the host immune responses and splenic clearance by regulating the expression of pir genes
- Open Access
- 14 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-27
Distinct evolution of type I glutamine synthetase in Plasmodium and its species-specific requirement
Malaria parasite lacks canonical pathways for amino acid biosynthesis and depends primarily on hemoglobin degradation and extracellular resources for amino acids. Interestingly, a putative gene for glutamine synthetase (GS) is retained despite glutamine being an abundant amino acid in human and mosquito hosts. Here we show Plasmodium GS has evolved as a unique type I enzyme with distinct structural and regulatory properties to adapt to the asexual niche. Methionine sulfoximine (MSO) and phosphinothricin (PPT) inhibit parasite GS activity. GS is localized to the parasite cytosol and abundantly expressed in all the life cycle stages. Parasite GS displays species-specific requirement in Plasmodium falciparum (Pf) having asparagine-rich proteome. Targeting PfGS affects asparagine levels and inhibits protein synthesis through eIF2α phosphorylation leading to parasite death. Exposure of artemisinin-resistant Pf parasites to MSO and PPT inhibits the emergence of viable parasites upon artemisinin treatment.
- 14 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-27
Open AccessDistinct evolution of type I glutamine synthetase in Plasmodium and its species-specific requirement
Malaria parasite lacks canonical pathways for amino acid biosynthesis and depends primarily on hemoglobin degradation and extracellular resources for amino acids. Interestingly, a putative gene for glutamine synthetase (GS) is retained despite glutamine being an abundant amino acid in human and mosquito hosts. Here we show Plasmodium GS has evolved as a unique type I enzyme with distinct structural and regulatory properties to adapt to the asexual niche. Methionine sulfoximine (MSO) and phosphinothricin (PPT) inhibit parasite GS activity. GS is localized to the parasite cytosol and abundantly expressed in all the life cycle stages. Parasite GS displays species-specific requirement in Plasmodium falciparum (Pf) having asparagine-rich proteome. Targeting PfGS affects asparagine levels and inhibits protein synthesis through eIF2α phosphorylation leading to parasite death. Exposure of artemisinin-resistant Pf parasites to MSO and PPT inhibits the emergence of viable parasites upon artemisinin treatment.